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According to the National Center for Health
Statistics (NCHS), in the year 2000 more than
4 million children were born in the United
States (NCHS 2002), and according to the
U.S. Census Bureau, 72 million children
younger than 18 years were living in the United
States, accounting for approximately one-
fourth of its population (U.S. Census Bureau
2000). Children are our future; however, in
2001 more than 27,000 children died in the
United States. The leading causes of deaths
among children varied with the age group; for
example, the leading causes of death among
infants were birth defects and conditions associ-
ated with premature births. Approximately 3%
of children in the United States were born with
a major birth defect; approximately 17% of
children had some type of developmental dis-
order; and an estimated 31% had a chronic
health problem (Arias et al. 2003). The reasons
for many of these adverse health conditions are
not known, although some can be linked to
known environmental exposures.
In 1997 the President’s Task Force on
Environmental Health Risks and Safety Risks
to Children was charged with developing
strategies to reduce or eliminate adverse effects
on children (up to 21 years of age) caused by
environmental exposures. The task force pro-
posed a longitudinal cohort study of the effects
of environmental exposure (broadly defined)
on the health and development of children.
Subsequently, the Children’s Health Act of
2000 (2000) authorized the National Institute
of Child Health and Human Development
(NICHD) to conduct a national longitudinal
study of environmental influences (including
physical, chemical, biologic, and psychologi-
cal) on children’s health and development.
To lead the planning and implementation
of the study, staff and funds have been allo-
cated by the NICHD, National Institute of
Environmental Health Sciences (NIEHS),
Centers for Disease Control and Prevention
(CDC), and the U.S. Environmental Protection
Agency (EPA). Investigators from each of these
four entities serve on the National Children’s
Study (NCS) Interagency Coordinating
Committee, which has further developed the
conceptual framework for the NCS (NCS
2001). Various work groups are charged with
providing technical guidance to the federal
advisory committee of the NCS. Our work
group, the Exposure to Chemical Agents
Working Group, is charged with characterizing
various means of assessing exposure for those
hypotheses requiring exposure assessment
(NCS Interagency Coordinating Committee
2003). Our work group primarily considered
exposures to chemicals found in the environ-
ment that we may have contact with in our
daily lives (environmental chemicals) and to
selected biologic and physical agents.
Exposure Pathways
When examining a population for adverse
health impacts that result, in part, from envi-
ronmental insults, it is essential to try to link
those impacts with exposures to selected chem-
ical, biologic, and physical agents that occur in
our daily environment. We consider not only
the known toxicity and the concentration of a
given agent to which an individual or a popu-
lation is exposed but also the frequency, dura-
tion, pathways, and routes of these exposures.
In addition the developmental life stage of the
person(s) exposed is of fundamental impor-
tance (U.S. EPA 2001). For example, many
researchers believe that some health end points
that manifest at various stages of development
are a result of exposures that occurred soon
after conception. They also deem the critical or
most susceptible time period for environmen-
tal exposures as in utero through 2 years of age,
especially for some neurobehavioral outcomes.
Other research suggests prepubertal exposures
are significant; for example, prepubertal males
highly exposed to 2,3,7,8-tetrachlorodibenzo-
p-dioxin later fathered predominantly female
children (Mocarelli et al. 2000). There are
various means for assessing children’s expo-
sures to environmental agents (Needham and
Sexton 2000). However, before discussing
these methods, we must examine the path-
ways of these agents that lead to exposure and
ultimately to dose.
Exposure is defined as contact between an
agent and a target; contact takes place at an
exposure surface over an exposure period
[World Health Organization (WHO) 2002;
Zartarian et al. 1997). In the NCS various
hypotheses linking exposures and health end
points will be tested. The agents of concern to
certain hypotheses are selected environmental
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chemical, biologic, and physical agents; the
targets are children; the exposure surfaces are
the external surfaces of the children (i.e., skin,
mouth, and nasal passage); and the exposure
period is the child’s lifetime or a defined
portion of that lifetime. The continuum
(Figure 1) often used to describe the human
exposure assessment pathway starts with the
agent at its origin or its source, which, for
example, can be a chemical manufacturing
plant, automobile exhaust, or a chemical waste
site. The agent can undergo various fate (e.g.,
transformation to another chemical) and
transport (e.g., long-range air transport or
leaching from soil into groundwater) steps in
the environment. This may lead to multiple
intermediate sources in the pathway for a
given agent; eventually, humans may have
contact with the environmental media that
contain the agent or its environmental trans-
formation products. The exposure mass may
pass through membranes and enter into the
body’s circulatory system by three routes:
ingestion, inhalation, and dermal absorption.
Depending on the membrane absorption co-
efficients and other bioavailability factors, the
agent (or its metabolite) can be absorbed into
the bloodstream. This absorbed dose of the
agent or metabolite [or its reaction product
(adduct)] is also known as the internal dose.
This internal dose can be directly eliminated
(usually a minor route); distributed within the
body to other organs including the target
organ(s); metabolized and eliminated (usually
in urine); metabolized and distributed within
the body to other organs including the target
organ; or some combination of these
(Needham et al. 2004). A portion of the dose
at the target organ may be biologically effec-
tive (biologically effective dose) (Needham
et al. 1992). The process of estimating or
measuring the magnitude, frequency, and
duration of exposure to an agent, along with
the number and characteristics of the popula-
tion exposed, is called an exposure assessment
(WHO 2002; Zartarian et al. 1997); certainly
for health studies the term “exposure assess-
ment” includes assessing the dose within the
body (Figure 1).
Exposure Assessment
Methods and Their Uses
Exposures to the general population of the
United States may be very difficult to accurately
assess because we are generally exposed to low
levels of environmental chemicals, and the
exposure scenario may be episodic (occurring
only occasionally). The exposures may occur in
different settings (e.g., occupational) through
various pathways (including air and dietary)
and routes (inhalation, ingestion, dermal
absorption). For assessing exposures to environ-
mental agents (e.g., chemicals), there is no sin-
gle method that will capture all the needed
exposure information all the time. Because the
NCS will assess exposures of children at various
ages and life stages (Figures 1,2), impact or bur-
den to the study participants is a factor, espe-
cially when attempting to assess exposures
during the in utero and early childhood life
stages. Therefore, a method that is “best” for
assessing exposure to a given chemical at one
life stage may not be the “best” method for
assessing exposure to that same chemical at a
different life stage.
Three main methods are used to assess
human exposures to chemical and biologic
agents: questionnaires and other indirect
means, environmental monitoring including
personal monitoring, and biomonitoring. All
these methods seek to gain information on
the concentrations of the agent(s) to which
the person(s) may have been exposed, the
duration and frequency of that exposure, and
an estimation of their internal dose. Other
data that should be factored into the assess-
ment, especially when the human population
being studied contains fetuses and children,
are the timing of the exposure (or when the
exposure took place) during those critical
susceptible periods of development. The three
means of assessing exposures to these agents
are discussed below.
Questionnaires help researchers acquire
needed individual exposure and potential
effect information such as demographic char-
acteristics, lifestyle activities including nutri-
tional status and exercise regimen, and
medical history including medications that is
unavailable through other methods. These
factors can affect the environmental chemi-
cal’s pharmacokinetics [absorption, distribu-
tion, metabolism (biotransformation), and
elimination], which can influence the biologi-
cally effective dose, and pharmacodynamics,
which can influence the health effects.
Therefore, this information is crucial for the
NCS. Questionnaires have also been used for
developing exposure indices for study partici-
pants. These exposure classification indices
consist of two types of information: the
concentrations of the chemical with which
participants have contact (exposure) and the
frequency/duration of that exposure. In gen-
eral, questionnaires provide more accurate
data on the frequency/duration aspect of the
index compared with the concentration com-
ponent. Once developed, these exposure
indices must be validated by using a more
direct exposure assessment method such as bio-
logic or environmental monitoring. However,
questionnaires are more frequently used to
give complementary data to the actual expo-
sure assessment. One example of where expo-
sure indices developed by questionnaires may
be of most use is in estimating the dose of cer-
tain ingredients in personal care products that
are applied directly to the skin (Figure 1).
However, for reasons given below, it is still
preferred to validate these estimates through
biomonitoring if possible.
Questionnaires can be self-administered
or interviewer administered. Both require a
high level of expertise in writing the question-
naire and, for the latter, in administering the
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Figure 1. Source to exposure to health effects pathway. Figure 2. Life stages of interest in the NCS.
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questionnaire. The questionnaire must
acquire the necessary information in a clear,
unbiased manner but yet not be so lengthy
that it presents an undue burden (which leads
to boredom and to inaccurate information) to
the study participant. Questionnaire data may
suffer from the disadvantage of information
bias, especially recall bias, which can lead to
inaccurate exposure and outcome classifica-
tions. The use of questionnaires is discussed
in more detail in our work group’s white
paper (NCS 2004).
Information from other indirect methods
such as geographic information systems (GIS)
and videotaping is also limited by not provid-
ing actual concentration data for the agent in
environmental and human specimens. Video-
taping has the advantages of tracing a given
individual throughout his/her activities in daily
life and observing potential contacts with the
agent of concern and the frequency/ duration
of these contacts. Videotaping is particularly
useful for recording the potential for transfer-
ring an agent from the outer surfaces of the
body into, for example, the mouth, for record-
ing such actions as hand-to-mouth activity.
GIS uses computerized maps to integrate
potential exposure data (e.g., from estimated
pollution data) into a spatial form so that the
data can be analyzed geographically. GIS data
are often used when more direct monitoring
data are not available. In the future GIS infor-
mation on both potential exposures and the
occurrence of disease will be mapped globally,
nationally, regionally and locally. One of the
more important issues in using GIS informa-
tion is how to integrate data gathered at differ-
ent levels of spatial resolution (e.g., ZIP code,
city, county, and region) into a final data
analysis (Viner et al. 1997). As for exposure
data gathered by questionnaires, we urge that
for the NCS, measurements in environmental
or biologic samples be performed to validate
exposure assessments.
Environmental measurements, that is, the
measurement of a chemical agent or its trans-
formation product in an environmental
medium, provide information that can be
used to track the chemical from its source
throughout the environment—air, water,
food, soil, dust, etc.—up to its human contact.
Consequently, environmental measurements
are especially useful in risk management, where
one is concerned about interrupting the
pathway to exposure and preventing further
environmental contamination and human
exposure. In addition these measurements have
been used as the metric for risk assessment. For
example, reference concentrations/doses and
cancer unit risks are expressed as an environ-
mental concentration that can then be com-
pared with an exposure estimate to determine
whether an adverse health risk is likely.
Environmental data are of most use when there
is a single predominant environmental matrix
such as air involved in the exposure pathway. If
the environmental pathway is multimedia,
then the number of potential measurements
(and hence costs) to assess this cumulative
exposure increases dramatically, and the data
are more difficult to model for the purpose of
predicting human exposures and particularly
the internal doses. In the exposure index para-
digm, environmental monitoring provides us
with information about the concentration of
the chemical(s) to which humans are poten-
tially exposed and potential routes of exposure,
whereas questionnaire information provides
the data on the duration and frequency of
exposure and the timing of the exposures.
Thus, this combination of environmental
monitoring and questionnaire information
provides needed information on the potential
dose, which may be useful for regulatory pur-
poses. However, for health studies, we are most
concerned with the biologically effective dose
at the target organ of the exposed individual;
therefore, models must be developed to esti-
mate the amount of the chemical to which the
population is exposed and furthermore, the
amount that is absorbed into the body and
becomes the internal dose and ultimately the
biologically effective dose (Burke et al. 2001;
MacIntosh et al. 1995; Ott 1985; Özkaynak
1999; Ryan 1991; Zartarian et al. 2000).
These models, if possible, should be calibrated
and validated before being used.
Air pollutants are some of the most meas-
ured environmental chemicals. They can be
measured in the air itself or by personal expo-
sure monitors. Depending on several factors,
including the chemicals to be monitored,
active or passive sampling may be used. Active
sampling involves drawing the air into the col-
lection unit with a sampling pump, whereas
passive sampling relies upon diffusion. In both
sampling processes, the collection unit should
be located within 30 cm of the nose and
mouth (i.e., in the “breathing zone”). Personal
air monitoring is an important component in
estimating exposure concentrations in certain
exposure scenarios, but again the uptake data
for the chemical and pharmacokinetic data
have to be modeled for the exposed individual.
Disadvantages of personal air monitoring and
environmental air monitoring include the lack
of accounting for differences of breathing rates
and volumes of air inhaled among people or
within a person, for example, during physical
exercise.
A concern in all methods used for human
exposure assessment is the burden on the study
population. However, the use of environmental
monitoring plus questionnaire information may
present no more burden on the study popula-
tion than the questionnaire itself, but this is
usually not the case. For example, if indoor air
is monitored, equipment must be installed in
the home; if food is monitored, then duplicate
diets may be taken; and if personal air monitors
are used, they must be installed on the individ-
ual. However, many developments in monitor-
ing personal exposures to airborne chemicals
and particulates are ongoing. These develop-
ments include portable chemical sensors and
clothing ranging from bracelets to smart shirts
that will allow the assessment not only of
chemicals in the air but also of chemicals com-
ing into contact with clothing; furthermore,
the clothing devices can denote physiologic
changes such as heart rate.
Assessing personal exposures in health
studies such as the NCS often relies upon par-
tial information on measured concentrations of
chemicals in various microenvironments of
concern. Consequently, the use of limited out-
door or indoor monitoring information can
lead to exposure misclassification biases that in
turn may result in loss of statistical power or
potential for obtaining a null result when actu-
ally an association between exposure and disease
exists (Özkaynak et al. 1986; Özkaynak and
Spengler 1996). To minimize errors in estimat-
ing personal exposures, researchers identify key
sources, media, routes, and pathways of con-
cern for each environmental pollutant and then
determine an optimum sampling and analysis
plan. These plans should consider the stability
of the chemical in the environment as well as if
and how it is bound, suspended, or in solution.
In practice both budgetary and technical con-
straints often limit the extent of an environ-
mental monitoring program. Such a program’s
actual cost depends on the chemical, the num-
ber of matrices to be monitored, which matrices
are monitored, frequency of monitoring, and
the cost of the questionnaire.
One advantage of environmental monitor-
ing that is often overlooked is that it identifies
the route of exposure that is important infor-
mation for chemicals whose toxicities differ
depending upon the route of exposure. For
example, chemicals such as manganese and
polycyclic aromatic hydrocarbons that are
bound to particulate matter are potentially
more toxic when inhaled than when ingested.
Monitoring methods that do not account for
this might incorrectly assess the toxicity of
such an exposure.
The primary goal of an environmental epi-
demiologic study such as the NCS is to link
the biologically effective dose with the adverse
health outcome of interest. However, meas-
urements of the biologically effective dose are
most often impossible because the target organ
may not be known or, if known, cannot be
sampled. As a result, researchers most often
regress (work back from biologically effective
dose toward the source) on the exposure con-
tinuum (Figure 1) and attempt to measure the
absorbed dose or internal dose. Such measure-
ments are called biologic monitoring or
Needham et al.
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biomonitoring and provide information on
the internal dose integrated across environ-
mental pathways and routes of exposure; thus,
an advantage of biomonitoring is that it
directly considers the amount of the chemical
that is absorbed into the body’s systemic circu-
latory system. These concentrations can then
be entered into models such as physiologically
based pharmacokinetic models in order to
estimate the biologically effective dose (Mason
and Wilson 1999).
Procedures for collecting biologic samples
range from those that are invasive, such as the
drawing of blood, to those with little intrusion,
such as collecting urine samples from older chil-
dren. If one neglects the burden on the person
and the amount of blood that can be collected,
blood has inherent advantages for biomonitor-
ing, for regardless of the route of exposure, the
chemical must be absorbed into the blood-
stream and circulate to the tissues to have an
effect (exceptions would include direct inhala-
tion effects on the lung and also blistering
agents on skin). Blood is also a “regulated”
matrix; therefore, there is a constant amount of
blood for a given body weight, so measure-
ments can be “normalized” to this amount. The
other most commonly monitored biologic
matrix is urine, which serves as a “sink” for
many chemicals, especially the nonpersistent
chemicals (i.e., chemicals with short biologic
half-lives); the persistent chemicals are elimi-
nated primarily through the feces. The non-
persistent chemicals are generally found in the
urine not only as their original “parent” struc-
ture but more frequently as metabolites.
Measuring these metabolites to assess exposure,
however, may be problematic because multiple
chemicals may form the same metabolite and
because the environmental transformation
product (e.g., for organophosphorous pesti-
cides) may be the same chemical as the metabo-
lite, thereby confounding interpretation.
Nonetheless, urinary measurements can play a
vital role in assessing human exposure to many
environmental chemicals. To gain specificity,
these nonpersistent chemicals, such as chlor-
pyrifos and many volatile organic chemicals,
have been measured as the parent compound in
blood (Needham 2005; Whyatt et al. 2004).
Another way to gain specificity and increase the
time window for the exposure assessment for
certain nonpersistent chemicals is to measure
their reaction products or adducts, such as with
hemoglobin, albumin, or DNA.
For persistent chemicals (those that have
“long” half-lives on the order of months or
years in the environment and in humans),
biomonitoring data provide information as to
what chemical and how much actually enters
into people and accumulates; however, in most
cases, biologic monitoring data do not provide
information on the timing, the sources, or
routes of exposures. Persistent chemicals are
generally measured in blood or its components
(e.g., serum and plasma), in adipose tissue, or
in human milk. After exposure to persistent
chemicals, differences in pharmacokinetics
among various people will affect the internal
dose levels to some degree but not to the extent
of misclassification for the purposes of epi-
demiologic studies. Thus, biomonitoring is
generally considered to be the “gold standard”
for assessing human exposure to persistent
chemicals, provided the sample collection
medium is feasible. In the event that biomoni-
toring is not feasible (e.g., collection of 100 mL
blood from an infant for a dioxin measurement
is not feasible), an exposure index derived by
other methods for persistent chemicals, such
as environmental sampling combined with
questionnaires, should be considered.
For chemicals that have short half-lives,
biomonitoring data may become much more
difficult to interpret. If the exposure situation
is continuous or even continual, then the expo-
sure situation (not the chemical) could be
deemed “persistent” or “chronic” and biomoni-
toring plays a vital role in assessing human
exposure (Needham et al. 2004); however, if
the exposure is predominantly from one envi-
ronmental medium, then environmental moni-
toring and questionnaire data should also be
considered for assessing a child’s exposure.
Whenever exposures are inconsistent or
episodic, then biomonitoring, like other tech-
niques such as environmental monitoring, loses
much of its ability to track these exposures. In
this scenario the frequency of sampling and
hence the comparison of data from these sam-
plings and their associated costs are extremely
important issues.
For some chemicals or physical agents, we
have little or no means to assess their exposure
via biomonitoring. These include particulate
matter, asbestos, some of the air criteria pollu-
tants (e.g., oxides of nitrogen), and allergens.
Also, for some chemicals the nonspecificity of
the metabolite biomarker (depending on the
chemical and the biologic matrix used) may
make it difficult to determine the actual chem-
ical to which the population was exposed.
Another important point, especially for
inorganic chemicals, is that both environmen-
tal and biologic monitoring include the bio-
logically active specie(s) of the chemical, for
example, methyl mercury for assessing expo-
sure to mercury after fish consumption
(Needham et al. 2005a).
Regardless of whether data from question-
naires, environmental monitoring, biomonitor-
ing, or a combination of these techniques are
used for exposure assessment, these data need to
be modeled and linked to the biologically effec-
tive dose (Figure 1) and beyond to adverse
effect (disease) data. Another approach that can
potentially be used is to move through the
exposure continuum (Figure 1) and into the
effect portion of the continuum. This approach
involves monitoring for endogenous changes
(an effect) in the body [e.g., by using molecular
profiling to note changes in messenger RNA
(transcriptomics), proteins (proteinomics), and
endogenous metabolites (metabolomics)]
(Wilson and Suk 2003). Once these changes
are noted, we again regress on the exposure
continuum to focus on the agent(s) that can be
linked to these changes. This approach has
advantages, but certainly the specificity of link-
ing certain stressors (e.g., psychosocial and
nutritional) in addition to exposures to envi-
ronmental chemicals with such changes is
unclear at this time.
Analytical Methods Used in
Environmental and Biologic
Monitoring
Monitoring data on a global, national, and
regional basis are generally organized by media.
For example, the U.S. EPA lists several pro-
grams on its website (U.S. EPA 2004) that
monitor the United States or portions of the
United States for persistent bioaccumulative
toxicants in emission inventories, ambient air
and air deposition, water and ecosystem, food
monitoring, human exposure, and databases.
Another recent U.S. exposure monitoring
example of interest to the NCS is the National
Allergen Survey, which is being conducted by
the NIEHS and the Department of Housing
and Urban Development (NIEHS 2005). Such
survey data benefit the study designers of the
NCS. However, as mentioned above, we think
that for the NCS, monitoring individuals
should be the basis for the exposure assessment.
This means that the monitoring is conducted
primarily with environmental, biologic, or per-
sonal samplers, questionnaires, or a combina-
tion of these tools. The analytical methods for
actually measuring the amount of the chemical
or degraded product/metabolite in an environ-
mental or biologic sample are quite similar. The
method consists of three major steps: sample
preparation, which generally involves the sepa-
ration of the chemicals of interest from other
chemicals in the matrix; analysis, which may
involve further separation by, for example,
chromatography, but does involve detection
and quantification; and data handling.
Generally, the major step that has the most
matrix-dependent differences is the sample
preparation step. During method develop-
ment, we seek methods that allow us to moni-
tor multiple chemicals, which may have many
different chemical/physical properties but yet
maintain the features of accuracy, precision,
specificity, linearity and range, limit of detec-
tion (LOD), and ruggedness/robustness. We
must also think of cost and throughput. No
analytical chemical procedure optimally meets
all these criteria (Needham et al. 2002). For
the measurement of chemicals present in a
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matrix at extremely low concentrations (e.g.,
dioxin in blood at parts per quadrillion levels),
the method of choice is one that uses specific
cleanup procedures and high-resolution gas
chromatography/high-resolution mass spec-
trometry with isotope dilution technique for
quantification. This method is very expensive
(~ $750–1,000 per sample) and has relatively
low throughput. Other methods have less
sample preparation and use less expensive
equipment and thus are available in more lab-
oratories and have higher throughput. This is
the case for the monitoring of most environ-
mental chemicals. However, even then the
methods are expensive, with costs in the range
of low hundreds of dollars per sample. For the
NCS we should consider the use of lower-cost
screening procedures such as immunoassays;
however, if extensive sample preparation steps
are needed, immunoassay methods can also be
quite expensive. Generally, these procedures
have higher throughputs (dependent on the
degree of sample preparation) and require less
expensive equipment but suffer from problems
associated with cross-reactivity and hence
specificity.
Once the analytical data have been gener-
ated, one topic of particular concern in envi-
ronmental and biologic analyses is how to
report and statistically treat concentration lev-
els below the LOD. The LOD is defined by
the lowest concentration of a chemical that the
analytical method can measure and is deter-
mined by the measured value that differs in a
statistically significant manner from having
“zero” amount of the chemical in the sample
(Taylor 1990). Concentrations below the
LOD are an issue because of lack of analyte in
a sample or a high method LOD, which can be
the result of the efficiency of the analytical
method to prepare extracts free of potential
interferents (but still recover a high percentage
of the analytes of interest) and the sensitivity of
the instrumental system. Other factors such as
insufficient sample size or characteristics of the
analytical method can affect the method LOD;
for example, we often measure multiple ana-
lytes in an analytical run, and the more ana-
lytes that we measure in an analytical run, the
lower the sensitivity (and higher the LOD) for
the measurement process of all the analytes,
because of instrumental, recovery, or interfer-
ence reasons. Therefore, the use of multi-
analyte methods has many advantages, but
generally they have higher LODs than single-
analyte methods (Needham and Wang 2002).
In the NCS, multianalyte methods and small
amounts of sample matrix will be issues for
biomonitoring. Also in the NCS, multiple
instruments in multiple laboratories may well
be measuring the same chemicals in the same
matrices. The LOD should be determined in
each laboratory for each instrument (instru-
mental LOD) and for each method (method
LOD); frequently, the method LOD is calcu-
lated for each and every sample analyzed.
Certainly, if multiple laboratories are used, it is
best if they use the same, or at least compara-
ble, methods so that the LODs and other ana-
lytical criteria are similar; also, the sample
weight of all samples of the same metric should
be similar so that the LODs will be similar.
When measurements are calculated to be
less than the LOD, the concentrations are gen-
erally reported as “nondetectable” with the
LOD given. However, for parametric statistics,
a number must be assigned for each sample.
To circumvent this problem, single-value
approaches using fixed values ranging from the
most conservative value of zero, to one-half the
detection limit concentration, to the detection
limit divided by the square root of 2, to the most
“liberal” value—the detection limit itself—
have been used. However, Lubin et al. (2004)
generally recommend the use of multiple
imputations of missing data instead of single-
value approaches, which use either fixed or ran-
domly selected fill-in values. However, the
question remains as to how to report concen-
trations when they are below the LOD but the
computer produces a concentration number. Is
this computer number more accurate than any
number(s) generated by the imputation meth-
ods? Many scientists would argue that it is,
especially when a detector such as a mass spec-
trometer, which gives structural information of
the analyte, is used. If so, then how are concen-
trations in samples that give no signal or actu-
ally quantify as less than zero, after subtracting
out blank values, reported? In these cases most
would agree that the concentration value of
zero should be used for statistical purposes.
Certainly, this area of confluence between
chemistry and statistics calls for more work.
The analytical laboratory must be able to
demonstrate the method’s accuracy, precision,
specificity, linearity and range, LOD, and
ruggedness/robustness. Once this has been
done, a quality assurance/quality control pro-
gram must be established and enforced to eas-
ily allow the detection of systematic failures in
the methodology and to ensure that these
defined requirements are being maintained
over time and among laboratories (Needham
et al. 2002). The testing procedures used can
include proficiency testing to ensure accuracy
as measured against a known reference mater-
ial, repeat measurements of known materials to
confirm the validity of an analytical run and to
measure analytical precision, “round robin” or
interlaboratory studies to confirm reproducible
measurement values among laboratories, regu-
lar verification of instrument calibration, daily
assurance of minimal laboratory contamina-
tion by analyzing “blank” samples, and cross-
validations to ensure that multiple analysts and
instruments obtain similar analytical values.
Fortified and unfortified sample media can also
be used to assess potential contamination and
analytes losses through the collection, trans-
portation, and storage of samples. In addition
some public health laboratories in the United
States have been certified by the Center for
Medicare and Medicaid Services to comply
with all quality assurance/quality control para-
meters outlined in the Clinical Laboratories
Improvement Amendment (1988). Quality
assurance/quality control measures are applica-
ble not just to the analytical method but also to
all aspects of the measurement process—from
sampling design to sample collection (need to
ensure no or a defined amount of contamina-
tion), transport and storage of samples, analyti-
cal method, and data reporting; therefore, all
aspects of the measurement process must be
subject to a stringent quality assurance/quality
control protocol. Often overlooked in longitu-
dinal studies, which require the collection and
long-term storage of environmental and bio-
logic samples, is the effect of long-term storage
on the sample and the agent. Matrix-based
quality control samples containing the agent at
known or “analytically assigned” concentra-
tions should be stored under the exact condi-
tions as the study samples and periodically
monitored. Also, any new analytical method or
any change in the measurement process must
be documented and validated against the
method being used. Many parameters for
implementing or improving a quality assurance
program have been published (Schaller et al.
1991; Taylor 1990).
Conclusions
The exact strategy for exposure monitoring
directly depends on the study design; for exam-
ple, if the study design is a long-term longitu-
dinal cohort study of 100,000 children, fewer
direct (e.g., biomonitoring) exposure measures
may be collected for each child; but if it is a
series of smaller nested case–control studies,
more direct exposure measures can be made.
Regardless of the design, individual exposure
assessment will play a vital role because one
important, if not the most important, aspect of
many of the hypotheses is to associate individ-
ual exposures with adverse health outcomes.
Therefore, exposure and the resulting dose
concentrations must be assessed as accurately
and as totally as possible. For assessing expo-
sure and dose information to the participants
in the NCS, we encourage the use of data sets
and methods used from many sources, includ-
ing questionnaire and general population
nutritional and environmental chemical bio-
monitoring data from the National Health
and Nutrition and Examination Survey
(NHANES) (CDC 2003; NCHS 2003;
Needham et al. 2005b); food intake from the
U.S. Department of Agriculture’s Continuing
Survey of Food Intake by Individuals
(CSFII), which has now been combined with
Needham et al.
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Table 1. Chemicals and chemical classes of potential interest to the NCS.
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Salts and esters of 2,4,5-triclorophenoxyacetic acid
Salts and esters of 2,4-dichlorophenoxyacetic acid
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NHANES (Journal of Nutrition 2003); activity
patterns from the U.S. EPA’s National Human
Activity Pattern Survey (NHAPS) (Klepeis
et al. 2001); and many environmental monitor-
ing programs conducted by the U.S. EPA
(2005a). Even though these resources are help-
ful and provide guidance, the NCS should
assess exposure on an individual basis such as
was done in NHANES and in the pilot phase
of the National Human Exposure Assessment
Survey (U.S. EPA 2005b). The use of question-
naires will play a vital role, and the use of video-
taping and GIS may be considered in certain
scenarios. If the exposure pathway is primarily
via one environmental medium, then generally
that matrix should be monitored; however, the
importance of route to potency of the exposure
must be considered. Biomonitoring should be
used when possible in order to assess total expo-
sure to an individual or to validate and calibrate
any exposure index that is derived by other
means. If biomonitoring data reveal high expo-
sures within a segment of the population,
certainly environmental monitoring and ques-
tionnaire information should be used in an
attempt to determine the key sources and path-
ways of exposure and to mitigate the exposure.
To move the process forward, we have
compiled a list of chemical classes containing
individual substances of potential interest to
address the various hypotheses of the NCS
(Table 1). In subsequent tables presented in
accompanying article, we have determined and
prioritized for each life stage (age group),
which environmental metric or biologic matrix
would be preferred for assessing exposure to
these environmental chemicals (Barr et al.
2005; Bradman and Whyatt 2005). The bio-
logic samples and the amount of sample avail-
able for sampling are variable and depend on
the life stage of the child up to the point that
the child nears adulthood, at which time that
child is capable of reproducing and continuing
the generations in the life cycle. Whenever a
person is not involved in reproduction, that
person exits the cycle, as shown in Figure 2.
Questionnaire data would generally be used to
augment this exposure assessment. Other issues
we have addressed include storage and analyti-
cal methods. We recognize the need to deter-
mine the gaps in exposure measures and to
determine cheaper methods for accomplishing
the end goal, for example, the use of personal
air monitors, the use of tap water as a matrix if
drinking water is the primary pathway, biosen-
sor technology, etc. Thus, there is little doubt
that exposure assessment techniques will
improve during the course of this study.
In summary, our Exposure to Chemical
Agents Working Group has presented and
prioritized the various means of assessing
human exposure to a variety of environmental
chemical/biologic agents that will assist study
designers to develop exposure indices for
accurately estimating exposures during the life
stages of interest. We strongly suggest that the
outcome and study design work groups work
closely with us to ensure the highest quality
data possible.
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